临床肺科杂志
臨床肺科雜誌
림상폐과잡지
Journal of Clinical Pulmonary Medicine
2015年
11期
2040-2042
,共3页
杨恩华%左满凤%钟新%刘静%罗晓妹
楊恩華%左滿鳳%鐘新%劉靜%囉曉妹
양은화%좌만봉%종신%류정%라효매
3%氯化钠溶液%雾化吸入%毛细支气管炎%脑性瘫痪%婴儿
3%氯化鈉溶液%霧化吸入%毛細支氣管炎%腦性癱瘓%嬰兒
3%록화납용액%무화흡입%모세지기관염%뇌성탄탄%영인
3% hypertonic saline solution%aerosolized%bronchiolitis%cerebral palsy%infants
目的:探讨3%氯化钠溶液雾化吸入治疗脑性瘫痪(简称脑瘫)婴儿毛细支气管炎( BC)的疗效,为临床治疗经济条件较差的脑瘫患儿的BC提供依据。方法将75例脑瘫合并BC的婴儿随机分为两组:观察组35例,雾化吸入3%氯化钠溶液4 ml,对照组40例,雾化吸入“布地奈德2 ml+异丙托溴铵1.25 ml”,均为每8 h 1次。比较两组患儿肺部哮鸣音消失时间、湿啰音消失时间、临床疗效和不良反应。结果观察组和对照组相比,肺部哮鸣音消失时间和湿啰音消失时间之间的差异均无统计学意义( P>0.05);临床疗效,观察组91.43%,对照组95.00%,两组相比差异无统计学意义(P>0.05);不良反应,观察组为0,对照组5例(12.5%),两组相比差异有统计学意义(P<0.05)。结论3%氯化钠溶液雾化吸入治疗BC,疗效好、无副作用、费用低,特别适合治疗经济条件较差的脑瘫患儿的BC。
目的:探討3%氯化鈉溶液霧化吸入治療腦性癱瘓(簡稱腦癱)嬰兒毛細支氣管炎( BC)的療效,為臨床治療經濟條件較差的腦癱患兒的BC提供依據。方法將75例腦癱閤併BC的嬰兒隨機分為兩組:觀察組35例,霧化吸入3%氯化鈉溶液4 ml,對照組40例,霧化吸入“佈地奈德2 ml+異丙託溴銨1.25 ml”,均為每8 h 1次。比較兩組患兒肺部哮鳴音消失時間、濕啰音消失時間、臨床療效和不良反應。結果觀察組和對照組相比,肺部哮鳴音消失時間和濕啰音消失時間之間的差異均無統計學意義( P>0.05);臨床療效,觀察組91.43%,對照組95.00%,兩組相比差異無統計學意義(P>0.05);不良反應,觀察組為0,對照組5例(12.5%),兩組相比差異有統計學意義(P<0.05)。結論3%氯化鈉溶液霧化吸入治療BC,療效好、無副作用、費用低,特彆適閤治療經濟條件較差的腦癱患兒的BC。
목적:탐토3%록화납용액무화흡입치료뇌성탄탄(간칭뇌탄)영인모세지기관염( BC)적료효,위림상치료경제조건교차적뇌탄환인적BC제공의거。방법장75례뇌탄합병BC적영인수궤분위량조:관찰조35례,무화흡입3%록화납용액4 ml,대조조40례,무화흡입“포지내덕2 ml+이병탁추안1.25 ml”,균위매8 h 1차。비교량조환인폐부효명음소실시간、습라음소실시간、림상료효화불량반응。결과관찰조화대조조상비,폐부효명음소실시간화습라음소실시간지간적차이균무통계학의의( P>0.05);림상료효,관찰조91.43%,대조조95.00%,량조상비차이무통계학의의(P>0.05);불량반응,관찰조위0,대조조5례(12.5%),량조상비차이유통계학의의(P<0.05)。결론3%록화납용액무화흡입치료BC,료효호、무부작용、비용저,특별괄합치료경제조건교차적뇌탄환인적BC。
Objective To observe the clinical effect of aerosol inhalation of 3% hypertonic saline on bron-chiolitis ( BC) in infants with cerebral palsy ( CP) . Methods 75 cerebral palsy infants with bronchiolitis were ran-domly divided into two groups. The observation group was given the inhalation of 4 ml 3% hypertonic saline ( n=35), and the control group was given the inhalation of 2 ml budesonide and 1. 25 ml isopropyl bromide (n=40). Both groups were given once per 8 hours (q8h). The disappearance time of lung signs, clinical efficacy and adverse reactions were compared between the two groups. Results The disappearance time of lung signs and clinical efficacy showed no significant difference between the observation group ( 91. 43%) and the control group ( 95. 00%) ( P>0. 05), while the adverse reaction in observation group (0 case) was significantly lower than that in the control group (5 cases) (P<0. 05). Conclusion 3% hypertonic saline aerosol inhalation is effective, safe and economic in the treatment of bronchiolitis in infants with cerebral palsy.